Literature DB >> 12769150

The effect of variably tinted spectacle lenses on visual performance in cataract subjects.

Srilata Naidu1, Jason E Lee, Karen Holopigian, William H Seiple, Vivienne C Greenstein, Susan M Stenson.   

Abstract

PURPOSE: A body of clinical and laboratory evidence suggests that tinted spectacle lenses may have an effect on visual performance. The aim of this study was to quantify the effects of spectacle lens tint on the visual performance of 25 subjects with cataracts.
METHODS: Cataracts were scored based on best-corrected acuity and by comparison with the Lens Opacity Classification System (LOCS III) plates. Visual performance was assessed by measuring contrast sensitivity with and without glare (Morphonome software version 4.0). The effect of gray, brown, yellow, green and purple tinting was evaluated.
RESULTS: All subjects demonstrated an increase in contrast thresholds under glare conditions regardless of lens tint. However, brown and yellow lens tints resulted in the least amount of contrast threshold increase. Gray lens tint resulted in the largest contrast threshold increase.
CONCLUSIONS: Individuals with lenticular changes may benefit from brown or yellow spectacle lenses under glare conditions.

Entities:  

Mesh:

Year:  2003        PMID: 12769150     DOI: 10.1097/00140068-200301000-00005

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  2 in total

1.  Effect on falls of providing single lens distance vision glasses to multifocal glasses wearers: VISIBLE randomised controlled trial.

Authors:  Mark J Haran; Ian D Cameron; Rebecca Q Ivers; Judy M Simpson; Bonsan B Lee; Michael Tanzer; Mamta Porwal; Marcella M S Kwan; Connie Severino; Stephen R Lord
Journal:  BMJ       Date:  2010-05-25

Review 2.  Photokeratitis induced by ultraviolet radiation in travelers: A major health problem.

Authors:  M Izadi; N Jonaidi-Jafari; M Pourazizi; M H Alemzadeh-Ansari; M J Hoseinpourfard
Journal:  J Postgrad Med       Date:  2018 Jan-Mar       Impact factor: 1.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.